Karen L Hanson1, Monica Luciana. 1. Department of Psychology, University of Minnesota, Twin Cities, Minneapolis, MN 55455, USA.
Abstract
BACKGROUND: Use of MDMA (ecstasy), a serotonin neurotoxin, has been associated with memory impairment and psychological dysfunction. This study examined cognitive functioning in abstinent MDMA users and MDMA-naive controls. METHOD: Participants completed measures of intelligence, motor function, attention, memory span, verbal fluency, immediate and delayed verbal memory, and working memory. They were also assessed for the presence of psychopathology. In addition to comparing cognitive function in MDMA users relative to controls, the possibility that clinically dysfunctional MDMA use increases the risk of cognitive impairment was examined. RESULTS: MDMA users exhibited relative deficits in mnemonic and executive functions. Additionally, users that met DSM-IV substance use disorder criteria for lifetime MDMA abuse or dependence exhibited a number of additional deficits relative to those who did not meet these criteria. CONCLUSION: These findings suggest that clinically dysfunctional, rather than purely recreational, MDMA use is associated with cognitive impairment. Future research studies of diverse samples of users may shed light on the mechanisms that underlie these differences.
BACKGROUND: Use of MDMA (ecstasy), a serotonin neurotoxin, has been associated with memory impairment and psychological dysfunction. This study examined cognitive functioning in abstinent MDMA users and MDMA-naive controls. METHOD:Participants completed measures of intelligence, motor function, attention, memory span, verbal fluency, immediate and delayed verbal memory, and working memory. They were also assessed for the presence of psychopathology. In addition to comparing cognitive function in MDMA users relative to controls, the possibility that clinically dysfunctionalMDMA use increases the risk of cognitive impairment was examined. RESULTS:MDMA users exhibited relative deficits in mnemonic and executive functions. Additionally, users that met DSM-IV substance use disorder criteria for lifetime MDMA abuse or dependence exhibited a number of additional deficits relative to those who did not meet these criteria. CONCLUSION: These findings suggest that clinically dysfunctional, rather than purely recreational, MDMA use is associated with cognitive impairment. Future research studies of diverse samples of users may shed light on the mechanisms that underlie these differences.
Authors: Kevin Sean Murnane; Shane Alan Perrine; Brendan James Finton; Matthew Peter Galloway; Leonard Lee Howell; William Edward Fantegrossi Journal: Psychopharmacology (Berl) Date: 2011-10-13 Impact factor: 4.530
Authors: Paul P Allen; Anthony J Cleare; Francis Lee; Paolo Fusar-Poli; Nigel Tunstall; Cynthia H Y Fu; Micheal J Brammer; Philip K McGuire Journal: Psychopharmacology (Berl) Date: 2006-07-06 Impact factor: 4.530
Authors: Jonathan P Roiser; Robert D Rogers; Lynnette J Cook; Barbara J Sahakian Journal: Psychopharmacology (Berl) Date: 2006-08-29 Impact factor: 4.530
Authors: Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton Journal: Psychopharmacology (Berl) Date: 2006-11-03 Impact factor: 4.530
Authors: Chad A Bousman; Mariana Cherner; Kristen T Emory; Daniel Barron; Patricia Grebenstein; J Hampton Atkinson; Robert K Heaton; Igor Grant Journal: J Int Neuropsychol Soc Date: 2010-08-25 Impact factor: 2.892